Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Ending Cash Position : ¥1,632 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Jilin Aodong Pharmaceutical Group Co Ending Cash Position?

Jilin Aodong Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥1,632 Mil.

Jilin Aodong Pharmaceutical Group Co's quarterly Ending Cash Position declined from Sep. 2023 (¥1,858 Mil) to Dec. 2023 (¥1,720 Mil) and declined from Dec. 2023 (¥1,720 Mil) to Mar. 2024 (¥1,632 Mil).

Jilin Aodong Pharmaceutical Group Co's annual Ending Cash Position declined from Dec. 2021 (¥1,743 Mil) to Dec. 2022 (¥1,438 Mil) but then increased from Dec. 2022 (¥1,438 Mil) to Dec. 2023 (¥1,720 Mil).

Jilin Aodong Pharmaceutical Group Co Ending Cash Position Historical Data

The historical data trend for Jilin Aodong Pharmaceutical Group Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Aodong Pharmaceutical Group Co Ending Cash Position Chart

Jilin Aodong Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2,192.83

2,488.96

1,742.73

1,438.18

1,719.94

Jilin Aodong Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															1,115.11	1,938.68	1,858.33	1,719.94	1,631.98

Jilin Aodong Pharmaceutical Group Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Jilin Aodong Pharmaceutical Group Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1438.184	+	281.751
	=	1,720

Jilin Aodong Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1719.936	+	-87.956
	=	1,632

Jilin Aodong Pharmaceutical Group Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Jilin Aodong Pharmaceutical Group Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Aodong Pharmaceutical Group Co Ltd (SZSE:000623) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No. 2158, Jidong Street, Dunhua, CHN, 133700

Website

http://www.jlaod.com

Jilin Aodong Pharmaceutical Group Co Ltd is engaged in manufacturing of pharmaceuticals. Its products include Anshen Bunao Liquid, Antelope Cough Syrup, Yangxue Yin Oral Liquid, Xinnao Shutong Capsule, Calf Spleen Extract Injection, Xuefu Zhuyu Oral Liquid, and others.

Executives

Guo Shu Qin	Directors, executives
Wang Zhen Yu	Directors, Directors, and Executives
Zhao Da Long	Director
Yang Kai	Directors, executives
Li Xiu Lin	Director
Zhang Shu Yuan	Directors, executives
Chen Yong Feng	Supervisors
Zhang Ming Jing	Supervisors
Li An Ning	Supervisors
Lin Xiao Lin	Executives
Ying Gang	Director
Guo Li	Supervisors
Xu Dong Lin	Supervisors
Zhu Yan	Directors, executives
Li Li Ping	Supervisors

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Headlines

No Headlines